Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
Crossref DOI link: https://doi.org/10.1007/s12325-018-0790-1
Published Online: 2018-09-25
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sabidó, Meritxell
Venkatesh, Saritha
Hayward, Brooke
Aldridge, Julie
Gillett, Alan
Funding for this research was provided by:
Merck KGaA
Article History
Received: 29 June 2018
First Online: 25 September 2018